For the forward looking investors, it's not all grim:
- No net debt;
- Very little tax payable this year because of the write-downs;
- Great cash flow and underlying profit;
- The ability to buy debt ledgers at much better prices (more profit in future years).
CCP has shown in the past how well it comes out of financial crisis periods, and this time it is in a much better financial position to take advantage of investment opportunities.
- Forums
- ASX - By Stock
- CCP
- Ann: FY2020 Unaudited results update
Ann: FY2020 Unaudited results update, page-5
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CCP (ASX) to my watchlist
|
|||||
Last
$14.36 |
Change
0.000(0.00%) |
Mkt cap ! $977.4M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 31 | $15.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.65 | 130 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 31 | 15.790 |
1 | 85 | 15.120 |
1 | 17 | 14.690 |
1 | 1 | 14.600 |
1 | 462 | 14.460 |
Price($) | Vol. | No. |
---|---|---|
13.650 | 130 | 2 |
13.970 | 4 | 1 |
14.100 | 5 | 1 |
14.110 | 52 | 3 |
14.340 | 348 | 1 |
Last trade - 09.59am 16/07/2024 (20 minute delay) ? |
Featured News
CCP (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online